(Q34308807)

English

A randomized, double-blind, controlled trial evaluating the effect of intranasal insulin on neurocognitive function in euthymic patients with bipolar disorder

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

A randomized, double-blind, controlled trial evaluating the effect of intranasal insulin on neurocognitive function in euthymic patients with bipolar disorder (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

0 references

bipolar disorder

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Anthony L Vaccarino

object named as

Anthony Vaccarino

5

0 references

Joanna K Soczynska

object named as

Joanna K Soczynska

2

0 references

Roger S McIntyre

1

object named as

Roger S McIntyre

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

author name string

Hanna O Woldeyohannes

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Andrew Miranda

4

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Glenda Macqueen

6

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Gary F Lewis

7

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Sidney H Kennedy

8

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

publication date

1 November 2012

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Bipolar Disorders

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

697-706

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

The International Society for Bipolar Disorders-Battery for Assessment of Neurocognition (ISBD-BANC).

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12006

21 January 2018

Neurocognitive impairment in euthymic patients with bipolar affective disorder

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12006

21 January 2018

Cognitive dysfunctions in bipolar disorder: evidence of neuropsychological disturbances.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12006

21 January 2018

Prediction of real-world functional disability in chronic mental disorders: a comparison of schizophrenia and bipolar disorder.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12006

21 January 2018

Regional cerebral cortical thinning in bipolar disorder.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12006

21 January 2018

Insulin signaling in the central nervous system: learning to survive

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12006

21 January 2018

Insulin and neurodegenerative disease: shared and specific mechanisms

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12006

21 January 2018

Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12006

21 January 2018

Impaired insulin sensitivity as indexed by the HOMA score is associated with deficits in verbal fluency and temporal lobe gray matter volume in the elderly

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12006

21 January 2018

Insulin resistance, inflammation, and cognition in Alzheimer's Disease: lessons for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12006

21 January 2018

Intranasal insulin improves memory in humans

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12006

21 January 2018

Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12006

21 January 2018

Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12006

21 January 2018

Measuring the severity of depression and remission in primary care: validation of the HAMD-7 scale.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12006

21 January 2018

A pilot study of visual backward masking performance among affected versus unaffected offspring of parents with bipolar disorder.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12006

21 January 2018

The Cognitive Failures Questionnaire (CFQ) and its correlates.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12006

21 January 2018

Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12006

21 January 2018

Placebo-controlled adjunctive trial of pramipexole in patients with bipolar disorder: targeting cognitive dysfunction

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12006

21 January 2018

Meta-analytic review of neurocognition in bipolar II disorder.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12006

21 January 2018

Cognitive effects of atypical antipsychotics: focus on bipolar spectrum disorders

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12006

21 January 2018

Intranasal insulin improves memory in humans: superiority of insulin aspart.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12006

21 January 2018

Neuropsychological task performance in bipolar spectrum illness: genetics, alcohol abuse, medication and childhood trauma

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12006

21 January 2018

The neurocognitive performance of drug-free and medicated euthymic bipolar patients do not differ.

1 reference

https://api.crossref.org/works/10.1111%2FBDI.12006

21 January 2018

Identifiers

10.1111/BDI.12006

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34308807&oldid=1546589781"